S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

SANA Sana Biotechnology Inc

7.50

0.00 (0.00%)

Pre Market

Last Updated: 18:06:42

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Sana Biotechnology (NASDAQ:SANA)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Sana Biotechnology Charts.

Sana Biotechnology (NASDAQ:SANA)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Sana Biotechnology Charts.

Sana Biotechnology Inc News

Form S-8 - Securities to be offered to employees in employee benefit plans
Thursday 9 May 2024 (1 day ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 9 May 2024 (2 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 9 May 2024 (2 days ago) • Edgar (US Regulatory)

Sana Biotechnology Reports First Quarter 2024 Financial Results and Business Updates
Thursday 9 May 2024 (2 days ago) • GlobeNewswire Inc.

Sana Biotechnology to Present at May and June 2024 Investor Conferences
Tuesday 7 May 2024 (4 days ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Sana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
Friday 1 March 2024 (2 months ago) • GlobeNewswire Inc.

Sana Biotechnology to Present at the Cowen 44th Annual Health Care Conference
Thursday 29 February 2024 (2 months ago) • GlobeNewswire Inc.

Form 3 - Initial statement of beneficial ownership of securities
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Sana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHP
Wednesday 14 February 2024 (3 months ago) • GlobeNewswire Inc.

More Sana Biotechnology Inc News Articles

Verizon Communications

National Australia Bank

Commonwealth Bank Of Aus...

Gold vs US Dollar

Sterling vs AUD

Australia And New Zealan...

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions